Tonix Pharmaceuticals, TONMYA, Cyclobenzaprine Hydrochloride, Fibromyalgia, Chronic Pain, RELIEF Study, RESILIENT Study, Phase III Clinical Trial, IASP 2026, World Congress on Pain,

Tonix Pharmaceuticals Reports Phase 3 Data Showing TONMYA® Improved Physical Symptoms and Functional Ability in Fibromyalgia

BERKELEY HEIGHTS, New Jersey, United States — October 27, 2026 Tonix Pharmaceuticals Holding Corp., a commercial-stage biopharmaceutical company focused...

By cGxPwire Editor
October 28, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Tonix Pharmaceuticals, TONMYA, Cyclobenzaprine Hydrochloride, Fibromyalgia, Chronic Pain, RELIEF Study, RESILIENT Study, Phase III Clinical Trial, IASP 2026, World Congress on Pain,

Tonix Pharmaceuticals Reports Phase 3 Data Showing TONMYA® Improved Physical Symptoms and Functional Ability in Fibromyalgia